FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912265709> ?p ?o ?g. }

• W2912265709 endingPage "10" @default.
• W2912265709 startingPage "1" @default.
• W2912265709 abstract "To characterize the disease progression and median survival of patients with prostate cancer (PCa) according to the prostatic-specific acid phosphatase (PAP) analysis in a population-based study from the Surveillance, Epidemiology, and End Results (SEER) database.Prostate cancer patients with completed PAP results were identified using the SEER database of the National Cancer Institute. The Mann-Whitney Sum test was utilized to compare the statistical significance for measurement data and ranked data. Data were stratified by ages, races, TNM Classification of Malignant Tumors (TNM), pathological grades, number of tumors, PAP, and survival duration. Multivariable logistic analysis was performed to identify predictors of the presence of invasion and metastases. Cox regression was analyzed for the factors associated with all-cause mortality and prostate cancer-specific mortality. Moreover, survival curve was used to detect the survival months. The unknown data were excluded from these tests.In total, there are 5184 PAP+ patients and 3161 PAP- patients involved. The Mann-Whitney Sum test showed that slightly greater tumor size (P = 0.03), elevated lymphatic (P = 0.005) and distant (P < 0.001) metastasis rate, higher pathological grade (P < 0.001), localized tumor number (P < 0.001), and shortened survival months (P < 0.001) were observed in the PAP+ group compared with the PAP- group. In the multivariable logistic regression, invasion and metastasis Hazard Ratio (HR) were elevated significantly (P < 0.001) in the PAP+ individuals. In the survival analysis, PAP- patients experienced the prolonged median survival. In the postsurgical patients, the survival months were still longer in PAP+ patients compared with the negative ones (P < 0.001), though surgery prolonged the survival months of both groups. Survival months stratified by localized, invasion, and metastasis situations were analyzed. In the three stratified subgroups, the survival duration is significantly decreased in the PAP+ individuals in the localized PCa group (P < 0.001) and the metastasis group (P = 0.013).The findings of this study provide population-based estimates of the PCa progress and prognosis for patients with different PAP results, which may suggest a renewed period for the PAP." @default.
• W2912265709 created "2019-02-21" @default.
• W2912265709 creator A5002092628 @default.
• W2912265709 creator A5006737896 @default.
• W2912265709 creator A5008043632 @default.
• W2912265709 creator A5011378633 @default.
• W2912265709 creator A5016504908 @default.
• W2912265709 creator A5033903580 @default.
• W2912265709 creator A5039085769 @default.
• W2912265709 creator A5040980276 @default.
• W2912265709 creator A5046851854 @default.
• W2912265709 creator A5050018283 @default.
• W2912265709 creator A5075740101 @default.
• W2912265709 creator A5087040288 @default.
• W2912265709 creator A5089966579 @default.
• W2912265709 date "2019-01-23" @default.
• W2912265709 modified "2023-10-15" @default.
• W2912265709 title "Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?" @default.
• W2912265709 cites W1602502274 @default.
• W2912265709 cites W163529261 @default.
• W2912265709 cites W1667831041 @default.
• W2912265709 cites W1961818598 @default.
• W2912265709 cites W1978504120 @default.
• W2912265709 cites W1989752811 @default.
• W2912265709 cites W2028945431 @default.
• W2912265709 cites W2051243190 @default.
• W2912265709 cites W2054783675 @default.
• W2912265709 cites W2060714317 @default.
• W2912265709 cites W2064686787 @default.
• W2912265709 cites W2071224786 @default.
• W2912265709 cites W2089216636 @default.
• W2912265709 cites W2089652639 @default.
• W2912265709 cites W2104172318 @default.
• W2912265709 cites W2148829197 @default.
• W2912265709 cites W2159242742 @default.
• W2912265709 cites W2160427174 @default.
• W2912265709 cites W2411360214 @default.
• W2912265709 cites W2474424080 @default.
• W2912265709 cites W2543129869 @default.
• W2912265709 cites W2575507671 @default.
• W2912265709 cites W2917837889 @default.
• W2912265709 doi "https://doi.org/10.1155/2019/7090545" @default.
• W2912265709 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6364107" @default.
• W2912265709 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30809318" @default.
• W2912265709 hasPublicationYear "2019" @default.
• W2912265709 type Work @default.
• W2912265709 sameAs 2912265709 @default.
• W2912265709 citedByCount "19" @default.
• W2912265709 countsByYear W29122657092019 @default.
• W2912265709 countsByYear W29122657092020 @default.
• W2912265709 countsByYear W29122657092021 @default.
• W2912265709 countsByYear W29122657092022 @default.
• W2912265709 countsByYear W29122657092023 @default.
• W2912265709 crossrefType "journal-article" @default.
• W2912265709 hasAuthorship W2912265709A5002092628 @default.
• W2912265709 hasAuthorship W2912265709A5006737896 @default.
• W2912265709 hasAuthorship W2912265709A5008043632 @default.
• W2912265709 hasAuthorship W2912265709A5011378633 @default.
• W2912265709 hasAuthorship W2912265709A5016504908 @default.
• W2912265709 hasAuthorship W2912265709A5033903580 @default.
• W2912265709 hasAuthorship W2912265709A5039085769 @default.
• W2912265709 hasAuthorship W2912265709A5040980276 @default.
• W2912265709 hasAuthorship W2912265709A5046851854 @default.
• W2912265709 hasAuthorship W2912265709A5050018283 @default.
• W2912265709 hasAuthorship W2912265709A5075740101 @default.
• W2912265709 hasAuthorship W2912265709A5087040288 @default.
• W2912265709 hasAuthorship W2912265709A5089966579 @default.
• W2912265709 hasBestOaLocation W29122657091 @default.
• W2912265709 hasConcept C10515644 @default.
• W2912265709 hasConcept C107130276 @default.
• W2912265709 hasConcept C121608353 @default.
• W2912265709 hasConcept C126322002 @default.
• W2912265709 hasConcept C143998085 @default.
• W2912265709 hasConcept C151956035 @default.
• W2912265709 hasConcept C207103383 @default.
• W2912265709 hasConcept C207886595 @default.
• W2912265709 hasConcept C2776235491 @default.
• W2912265709 hasConcept C2776490512 @default.
• W2912265709 hasConcept C2779013556 @default.
• W2912265709 hasConcept C2780192828 @default.
• W2912265709 hasConcept C2908647359 @default.
• W2912265709 hasConcept C29456083 @default.
• W2912265709 hasConcept C44249647 @default.
• W2912265709 hasConcept C50382708 @default.
• W2912265709 hasConcept C71924100 @default.
• W2912265709 hasConcept C99454951 @default.
• W2912265709 hasConceptScore W2912265709C10515644 @default.
• W2912265709 hasConceptScore W2912265709C107130276 @default.
• W2912265709 hasConceptScore W2912265709C121608353 @default.
• W2912265709 hasConceptScore W2912265709C126322002 @default.
• W2912265709 hasConceptScore W2912265709C143998085 @default.
• W2912265709 hasConceptScore W2912265709C151956035 @default.
• W2912265709 hasConceptScore W2912265709C207103383 @default.
• W2912265709 hasConceptScore W2912265709C207886595 @default.
• W2912265709 hasConceptScore W2912265709C2776235491 @default.
• W2912265709 hasConceptScore W2912265709C2776490512 @default.
• W2912265709 hasConceptScore W2912265709C2779013556 @default.
• W2912265709 hasConceptScore W2912265709C2780192828 @default.

• next